NCT04477421

Brief Summary

Comparison of femtosecond small incision lenticule extraction (FS-SMILE) versus Femtosecond laser Insitu Keratomileusis (FS-LASIK) regarding dry eye disease (DED) and corneal sensitivity (CS) after those refractive surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2018

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 20, 2020

Completed
Last Updated

July 20, 2020

Status Verified

July 1, 2020

Enrollment Period

1.7 years

First QC Date

July 14, 2020

Last Update Submit

July 17, 2020

Conditions

Outcome Measures

Primary Outcomes (10)

  • Ocular Surface Disease Index

    Ocular Surface Disease Index (the index range from 0 to 100), higher value indicate more severe disease

    After 1 month of surgery

  • Ocular Surface Disease Index

    Ocular Surface Disease Index (the index range from 0 to 100), higher value indicate more severe disease

    After 6 months of surgery

  • Tear Break-Up Time

    Tear Break-Up Time (in seconds)

    After 1 month of surgery

  • Tear Break-Up Time

    Tear Break-Up Time (in seconds)

    After 6 months of surgery

  • Schirmer I test

    Schirmer I test (in mm/5 minutes)

    After 1 month of surgery

  • Schirmer I test

    Schirmer I test (in mm/5 minutes)

    After 6 months of surgery

  • Oxford score

    Oxford score (the score range from 0 to 5), higher value indicate more severe disease

    After 1 month of surgery

  • Oxford score

    Oxford score (the score range from 0 to 5), higher value indicate more severe disease

    After 6 months of surgery

  • Dry Eye Work Shop scale

    Dry Eye Work Shop scale (value range from 0 to 4), higher value indicate more severe disease

    After 1 month of surgery

  • Dry Eye Work Shop scale

    Dry Eye Work Shop scale (value range from 0 to 4), higher value indicate more severe disease

    After 6 months of surgery

Study Arms (2)

FS-LASIK Group

ACTIVE COMPARATOR

100 eyes of 50 patients underwent bilateral FS-LASIK (Femtosecond laser Insitu Keratomileusis)

Procedure: S-LASIK

FS-SMILE

EXPERIMENTAL

100 eyes of 50 patients who underwent bilateral FS-SMILE (femtosecond small incision lenticule extraction)

Procedure: FS-SMILE

Interventions

FS-SMILEPROCEDURE

Femtosecond small incision lenticule extraction

FS-SMILE
S-LASIKPROCEDURE

Femtosecond laser Insitu keratomileusis

FS-LASIK Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • bilateral eyes with spherical correction range from -2 to -6 diopters and cylinder range from 0 to - 3.5 diopters

You may not qualify if:

  • sign or symptom of dry eye disease (tear film breakup time (TBUT) \>10 seconds
  • Schirmer I test \>10 mm /5 minutes)
  • corneal or conjunctival staining
  • Meibomian gland dysfunction
  • Previous ocular and or eyelid medical or surgical treatment
  • pregnancy
  • Chronic systemic disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Rasheed University College

Baghdad, AL-Adhmia, 12221, Iraq

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2020

First Posted

July 20, 2020

Study Start

March 1, 2017

Primary Completion

October 31, 2018

Study Completion

October 31, 2018

Last Updated

July 20, 2020

Record last verified: 2020-07

Locations